| 0–14 days | 15–30 days | 31–90 days | >90 days |
P* |
---|
pAEa
| 83%(6/12) | 92%(9/12) | 92%(11/12) | 92%(11/12) | 0.880 |
dALEb
| 96%(43/45) | 96%(43/45) | 96%(43/45) | 96%(43/45) | 1.000 |
prNMDAREc
| 100%(34/34) | 100%(34/34) | 100%(34/34) | 100%(34/34) | 1.000 |
-
*
P < 0.05 is significant
-
aspecificity of possible autoimmune encephalitis assessed by pAE(−)/non autoimmune encephalitis cases
-
bspecificity of definite autoimmune limbic encephalitis assessed by dALE(−)/non autoimmune limbic encephalitis cases
-
cspecificity of probable anti-NMDA receptor encephalitis assessed by prNMDARE(−)/non anti-NMDAR encephalitis cases